All our latest news

  • News
    May 4, 2024

    Crux Biolabs and KCAS Bio announce Global Spectral Flow Cytometry Alliance

    KCAS Bio has selected Crux Biolabs (Melbourne, Australia) as its partner in providing harmonised spectral flow cytometry across the US, Europe, and Australia.  The alliance enables KCAS Bio and Crux Biolabs to support the global needs of clinical research by…
    Read more
  • Scientific Leadership
    January 15, 2024

    Large molecule pharmacokinetics assay

    A key to better understanding the safety and effectiveness of a new therapeutic in humans is to consider its Absorption, Distribution, Metabolism and Excretion (ADME) and pharmacokinetic (PK) properties. PK studies result in the measurement of drug concentration in specific…
    Read more
  • Scientific Leadership
    January 15, 2024

    The importance of PBMCs in bioanalysis

    Peripheral blood is a key component in many clinical studies. From a single blood draw, multiple blood components can be isolated for numerous downstream applications. Changes in treatment responses can be measured with assays designed to detect biomarkers in circulating…
    Read more
  • Scientific Leadership
    January 15, 2024

    Measuring cell-mediated immunity (CMI) by Flow Cytometry

    Flow Cytometry is considered the method of choice to measure Cell-Mediated Immunity (CMI) by assessing the level of intracellular cytokines after antigen exposure. CMI is a branch of the adaptive immune response that allows protection against various pathogens. This protection…
    Read more
  • News
    April 30, 2023

    Introduction: Meet the New CEO of Crux Biolabs

    Discover the vision and goals of Crux Biolabs' new CEO in our in-depth interview. Learn about their background in the pharmaceutical industry and the company's plans for expanding bioanalytical services in Australia's R&D landscape.
    Read more
  • News
    March 9, 2023

    MesoScale Discovery (MSD) assays at Crux Biolabs

    MesoScale Discovery (MSD) immunoassays are used to measure the concentration of proteins or other molecules in biological samples. They detect multiple analytes in a single sample and are superior to Luminex because of a wider dynamic range, reduce matrix effects and increase sensitivity. MSD assays…
    Read more
  • News
    February 20, 2023

    The importance of Good Clinical Practice

    When it comes to clinical trials, it is all about the patient! Good Clinical Practice – or GCP as it is known - is a must for biolabs to ensure that their clinical trials are conducted ethically and scientifically. This…
    Read more
  • News
    January 16, 2023

    More on the Australian advantage: up to 43.5% cash back for every $1 spent on R&D in Australia

    When it comes to places to conduct research, few places globally offer better incentives than Australia. Known as the “Australian advantage”, not only does the land down under offer a fast and pragmatic regulatory environment for clinical studies (with a…
    Read more
  • News
    January 16, 2023

    21 colour flow cytometry with Crux Biolabs

    As so many of our partners have thrilled since earlier in the year when we launched our capability to provide 21 colour flow cytometry, we just had to do a shout out to it. As you no doubt know, flow…
    Read more
  • News
    December 16, 2022

    Crux Biolabs: expansion into chemistry

    After repeated inquiries from our customer base, Crux Biolabs are pleased to announce their expansion into chemistry analytical services in 2023. These services will be centred around UHPLC and LCMS instrumentation to be installed in our new, purpose-built lab space.…
    Read more